Leaderboards/Otitis Media and Relapsing Polychondritis

Otitis Media and Relapsing Polychondritis

Last updated July 7, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
Ifeyinwa E. Obiorah
University of Virginia Health System
2
Caspar I. van der Made
Radboud University Nijmegen
3
Ève Zakine
Hôpital Saint-Louis
4
Ava Diarra
Centre Hospitalier de Tourcoing
5
Fabien Théry
Ghent University
6
Mohamed-Yacine Khitri
Sorbonne Université
7
Thomas Barba
Hospices Civils de Lyon
8
Frederik Staels
AZ Maria Middelares
9
Marion Magnol
Institut universitaire du cancer de Toulouse Oncopole
10
Alexander Hines
WinnMed

Rising Stars Papers

1
Expanding the PRAAS spectrum: De novo mutations of immunoproteasome subunit β-type 10 in six infants with SCID-Omenn syndrome
The American Journal of Human Genetics|2024
23 cit.
2
VEXAS syndrome: An update
Joint Bone Spine|2024
22 cit.
3
Chemotaxis overrides the killing response in alloreactive CTLs, providing vascular immune privilege during cellular rejection
Journal of Clinical Investigation|2025
6 cit.
4
OTULIN haploinsufficiency predisposes to environmentally directed inflammation
Frontiers in Immunology|2024
5 cit.
5
Real-Life Cefiderocol Use in Bone and Joint Infection: A French National Cohort
Antibiotics|2025
3 cit.
6
Séronégativité et anti-CD20 : lorsqu’un traitement compromet le diagnostic
La Revue de Médecine Interne|2025
3 cit.
7
Outcomes in orthopedic device infections due to Streptococcus agalactiae: a retrospective cohort study
BMC Infectious Diseases|2024
2 cit.
8
Primary cutaneous melanoma of the breast skin: Incidence, characteristics, and management
JAAD International|2024
2 cit.
9
An 18-Year Review of Hemoglobinopathy Proficiency Testing: Recommendations From the College of American Pathologists Hematology and Clinical Microscopy Committee
Archives of Pathology & Laboratory Medicine|2025
1 cit.
10
Distinctive genomic features of hydroa vacciniforme lymphoproliferative disorder in Latin American patients: A multicenter multi-omics study
Journal of the American Academy of Dermatology|2025
1 cit.

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Francis Impens
Ghent University
2
Lilliana Radoshevich
National Jewish Health
3
Carlo Salvarani
University of Modena and Reggio Emilia
4
Samuele Ferrari
Vita-Salute San Raffaele University
5
Natalia Mena‐Vázquez
Hospital Regional Universitario de Málaga
6
Wencke Walter
Munich Leukemia Laboratory (Germany)
7
Jérôme Hadjadj
Sorbonne Université
8
François Chasset
Sorbonne Université
9
Eduardo Martín‐Nares
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán
10
Gabriela Cobos
Tufts Medical Center

Emerging Leaders Papers

1
Choice of template delivery mitigates the genotoxic risk and adverse impact of editing in human hematopoietic stem cells
Cell stem cell|2022
126 cit.
2
Immunopeptidomics-based design of mRNA vaccine formulations against Listeria monocytogenes
Nature Communications|2022
96 cit.
3
Efficacy and safety of targeted therapies in VEXAS syndrome: retrospective study from the FRENVEX
Annals of the Rheumatic Diseases|2024
64 cit.
4
Tocilizumab for treatment of cutaneous and systemic manifestations of vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic (VEXAS) syndrome without myelodysplastic syndrome
JAAD Case Reports|2022
63 cit.
5
Novel causative variants of VEXAS in UBA1 detected through whole genome transcriptome sequencing in a large cohort of hematological malignancies
Leukemia|2023
62 cit.
6
Rapid efficacy of anifrolumab in refractory cutaneous lupus erythematosus
Journal of the American Academy of Dermatology|2023
54 cit.
7
The role of PET/CT in disease activity assessment in patients with large vessel vasculitis
Lara D. Veeken|2022
52 cit.
8
Safety and Effectiveness of Abatacept in a Prospective Cohort of Patients with Rheumatoid Arthritis–Associated Interstitial Lung Disease
Biomedicines|2022
41 cit.
9
Mechanisms of hematopoietic clonal dominance in VEXAS syndrome
Nature Medicine|2025
39 cit.
10
Orbital and periorbital inflammation in VEXAS syndrome
Scandinavian Journal of Rheumatology|2022
34 cit.

Current Senior Leaders

Established & currently active

Current Senior Leaders Researchers

1
Leonard H. Calabrese
Cleveland Clinic
2
Joseph L. Mills
Baylor College of Medicine
3
D. Blöch
Centre National de la Recherche Scientifique
4
Anthony S. Fauci
Georgetown University
5
Gene G. Hunder
Mayo Clinic
6
Richard A. Watts
University of East Anglia
7
James F. Fries
Arthritis and Rheumatism Associates
8
Peter C. Grayson
National Institute of Arthritis and Musculoskeletal and Skin Diseases
9
Hasan Yazıcı
Istanbul University
10
D. Adu
University of Ghana

Current Senior Leaders Papers

1
The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis
Arthritis & Rheumatism|1988
19.9k cit.
2
2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides
Arthritis & Rheumatism|2012
6.6k cit.
3
Measurement of patient outcome in arthritis
Arthritis & Rheumatism|1980
4.4k cit.
4
Aging, Natural Death, and the Compression of Morbidity
New England Journal of Medicine|1980
3.3k cit.
5
The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis
Arthritis & Rheumatism|1990
2.5k cit.
6
Coronavirus Infections—More Than Just the Common Cold
JAMA|2020
2.3k cit.
7
Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy
Proceedings of the National Academy of Sciences|1997
2k cit.
8
HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease
Nature|1993
1.8k cit.
9
Detection of AIDS Virus in Macrophages in Brain Tissue from AIDS Patients with Encephalopathy
Science|1986
1.7k cit.
10
The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: Risk stratification based on Wound, Ischemia, and foot Infection (WIfI)
Journal of Vascular Surgery|2013
1.6k cit.

Reagents for Otitis Media and Relapsing Polychondritis

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

⭐ Top Rated

Best all-around

Cell Signaling TechnologyEvidence 65

c-Kit (Ab81) Mouse Monoclonal Antibody (Alexa Fluor® 488 Conjugate)

#3310$465
View Evidence →
Cell Signaling Technology

Phospho-eIF4B (Ser422) Antibody

#3591$148,362
View Evidence →

🌟 All-Time

Most validated

Cell Signaling TechnologyEvidence 60

CBX7 (E7N1W) Rabbit Monoclonal Antibody

#34547$175,376
View Evidence →
Acris AntibodiesEvidence 60

Mouse Anti-Canine Distemper Virus Monoclonal Antibody, Unconjugated, Clone 39937

#3CD10-5-4
View Evidence →
Acris Antibodies

Mouse Anti-CD154 / CD40L Monoclonal Antibody, Unconjugated Clone 2A3

#4CD40-2A3
View Evidence →